Andrea Constanza Ortiz Orrego, PhD

Pharmacology, Toxicology and Pharmaceutical Science

1. Lipid 100%
2. Nanocarrier 86%
3. Mesoporous Silica Nanoparticle 57%
4. Nanoparticle 46%
5. Nanomaterial 35%
6. Drug Release 32%
7. Mesoporous Silica 32%
8. Tablet 29%
9. Controlled Release 27%
10. Transferrin 26%
11. Antioxidant 22%
12. Hydrophile 20%
13. Antibacterial Activity 18%
14. Tableting 18%
15. Drug Administration 16%
16. Anticarcinogen 16%
17. Camptothecin 16%
18. Micelle 16%
19. Propolis 16%
20. Ciprofloxacin 16%
21. Biopharmaceutical 16%
22. Staphylococcus Aureus 16%
23. Rifampicin 16%
24. Zeta Potential 13%
25. Nanoformulation 13%
26. Gelucire 13%
27. Antibacterial Performance 12%
28. Silicon Dioxide 11%
29. Infection 10%
30. Helicobacter Pylori 10%
31. Doxorubicin 10%
32. IC50 10%
33. Excipient 9%
34. Antimicrobial Agent 9%
35. Buccal Drug Delivery 8%
36. Nifedipine 8%
37. Cell Viability 8%
38. Enzymes 8%
39. Antioxidant Capacity 7%
40. Bioavailability 7%
41. Antiinfective Agent 6%
42. Cytotoxicity Assay 6%
43. Rhodamine 123 6%
44. Drug Delivery System 6%
45. Caffeic Acid 6%
46. Biocompatibility 6%
47. Drug Solubility 5%
48. Polypeptide Antibiotic Agent 5%
49. Lung Cancer 5%
50. Neoplasm 5%